The stock had gained late Monday on news that the company plans to cut 40% of its workforce, but its latest 10-Q has 'going concern' language Shares of 23andMe Holding Co. fell 4% Tuesday after the ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D, but the benefits are years away and the risks are immediate. Eylea franchise revenues dropped 26% year-over-year as ...

On this episode of Stock Movers: - 23andMe (MEHCQ) shares are up as the bankrupt genetic-testing firm agreed to sell its data bank, which once contained DNA samples from about 15 million people, to ...

Bankrupt genetics company 23andMeMEHCQ wants to reopen bidding on its assets after former Chief Executive Anne Wojcicki put together a $305 million offer, topping Regeneron PharmaceuticalsREGN.

23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. Stream NBC 5 for free, 24/7, wherever ...

Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night. The company’s CEO, Anne Wojcicki, has ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer for ...

Sometimes a public company has a controlling shareholder who wants to take it private by buying out all of the other shareholders, and that’s always messy.1 The controlling shareholder will to some ...

As soon as the genetic testing company 23andMe filed for bankruptcy on March 23, 2025, concerns about what would happen to the personal information contained in its massive genetic and health ...

Add Yahoo as a preferred source to see more of our stories on Google. Genetic testing company 23andMe, once valued at $6 billion, has filed for bankruptcy. State attorneys general are urging concerned ...